SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMCNet:  Research and Markets: Alzheimer's Pipeline Drugs Review, Alzheimer's Disease Drug Market & Forecast - Global Analysis

[December 03, 2013]

Research and Markets: Alzheimer's Pipeline Drugs Review, Alzheimer's Disease Drug Market & Forecast - Global Analysis

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/hhzqpr/alzheimers) has announced the addition of the "Alzheimer's Pipeline Drugs Review, Alzheimer's Disease Drug Market & Forecast - Global Analysis" report to their offering.

Alzheimer's disease drug market is on the curvature stage. Since 2003, there is not any single magic bullet launched in the market to prevent or cure it. However, all current marketed products are going to be generic in the next 3-4 years. There are high unmet medical needs. The current unmet needs represent a huge opportunity for pharmaceutical companies which are developing targeted novel therapies. If successful, they will be in a position to command premium prices and tap the existing opportunity. Lot of drugs has failed in Phase III stage thus putting a greater impact on Alzheimer's disease drug market.

From the year 2009 Alzheimer's disease drug market is declining and it is expected to fall till 201. But with the expected launch of some Alzheimer's drugs from the year 2017 onwards, Alzheimer's disease drug market is expected to revive in the coming years. However due to absence of exact potential drugs there will always remain a huge Unmet Alzheimer's Drug Market. For the year 2018 Alzheimer's Disease Drug Market will be just 10% of Unmet Alzheimer's Disease Drug Market.


This report provides a comprehensive assessment of this fast-evolving, high-growth global market.

Present & Pipeline Drugs Studied in this Report

  • Namenda
  • Ebixa
  • Axura
  • Aricept
  • Nootropil
  • Exelon
  • Memary
  • Solanezumab
  • LuAe58054

Key Topics Covered

1. Executive Summary

2. Worldwide - Alzheimer's Disease Drug Market Analysis

3. Failed Alzheimer's Drugs

4. Worldwide - Alzheimer's Disease Drug Market Share & Forecast

5. Worldwide - Alzheimer's Drug Brands Market Performance

6. Pipeline Drugs Analysis in Alzheimer's Disease Market

7. M&A, Licensing Agreement, Strategic Alliances & Collaboration Deals in Alzheimer's Disease Drug Market

8. Funding in Alzheimer's Disease Drugs Research

9. Key Drivers of Growth in Global Alzheimer's Disease Drug Market

10. Key Challenges in the Global Alzheimer's Disease Drug Market

Companies Mentioned

  • Eli Lilly
  • Genentech
  • Lundbeck
  • Merck
  • Roche
  • Targacept/AstraZeneca
  • TauRx Therapeutics

For more information visit http://www.researchandmarkets.com/research/hhzqpr/alzheimers

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.


[ Back To Technology News's Homepage ]

OTHER NEWS PROVIDERS







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved.